bluebird bio BLUE announced that the FDA has extended the review period of biologics licensing applications (BLAs) for betibeglogene autotemcel (beti-cel) and elivaldogene autotemcel (eli-cel) as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results